99 related articles for article (PubMed ID: 1448470)
21. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
Dursun SM; Handley SL
Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
[TBL] [Abstract][Full Text] [Related]
22. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
Riekkinen P
Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
[TBL] [Abstract][Full Text] [Related]
23. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
[TBL] [Abstract][Full Text] [Related]
24. The time-course for up- and down-regulation of the cortical 5-hydroxytryptamine (5-HT)2A receptor density predicts 5-HT2A receptor-mediated behavior in the rabbit.
Dave KD; Harvey JA; Aloyo VJ
J Pharmacol Exp Ther; 2007 Oct; 323(1):327-35. PubMed ID: 17640952
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
26. Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome.
Hayslett RL; Tizabi Y
Pharmacol Biochem Behav; 2003 Dec; 76(3-4):409-15. PubMed ID: 14643839
[TBL] [Abstract][Full Text] [Related]
27. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
28. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
Welch JE; Saphier D
J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA/2J mice: I. Effects of D2/D3 and D2 dopamine receptor selective compounds.
Rangel-Barajas C; Malik M; Vangveravong S; Mach RH; Luedtke RR
Neuropharmacology; 2014 Aug; 83():18-27. PubMed ID: 24680675
[TBL] [Abstract][Full Text] [Related]
30. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
Ferry RC; Unsworth CD; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
[TBL] [Abstract][Full Text] [Related]
31. Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats.
Hadamitzky M; Feja M; Becker T; Koch M
Behav Pharmacol; 2009 Sep; 20(5-6):415-23. PubMed ID: 19730369
[TBL] [Abstract][Full Text] [Related]
32. Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette's syndrome.
Hayslett RL; Tizabi Y
Pharmacol Biochem Behav; 2005 Aug; 81(4):879-86. PubMed ID: 16045972
[TBL] [Abstract][Full Text] [Related]
33. DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities.
Cohen ML; Johnson MP; Schenck KW; Susemichel A; Wainscott DB; Robertson DW; Nelson DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):943-9. PubMed ID: 8355216
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
Li Q; Brownfield MS; Battaglia G; Cabrera TM; Levy AD; Rittenhouse PA; van de Kar LD
J Pharmacol Exp Ther; 1993 Aug; 266(2):836-44. PubMed ID: 8394920
[TBL] [Abstract][Full Text] [Related]
35. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
[TBL] [Abstract][Full Text] [Related]
36. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
[TBL] [Abstract][Full Text] [Related]
37. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
Gorzalka BB; Hill MN; Sun JC
Eur J Pharmacol; 2005 May; 516(1):28-33. PubMed ID: 15913602
[TBL] [Abstract][Full Text] [Related]
38. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
Akiyoshi J; Hough C; Chuang DM
Mol Pharmacol; 1993 Mar; 43(3):349-55. PubMed ID: 8383800
[TBL] [Abstract][Full Text] [Related]
39. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
Rabin BC; Guo TZ; Gregg K; Maze M
Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
[TBL] [Abstract][Full Text] [Related]
40. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
Lawton CL; Blundell JE
Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
